Farooq A Wandroo retweeted
Draft @NICEComms guidance for #pirtobrutinib
Provisionally approved for
R/R CLL
Post cBTKI
Ven Exposed or Naive
Final guidance pending #CLL #pirtobrutinib
Farooq A Wandroo retweeted
NEW BMJ Research: Weight regain after cessation of medication for weight management
bit.ly/4jy1ezY
@_WestSam
Linked Editorial exploring how weight management drugs are no magic bullets for treating obesity
bit.ly/3LBnnkj
Farooq A Wandroo retweeted
🔹 @BritSocHaem Guideline🔹
Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations: A British Society for Haematology Guideline
buff.ly/I0zHrBx
Farooq A Wandroo retweeted
#ASH25 Key abstract to watch in acute myeloid leukemia #AML #leusm 🧵
Overall Takeaways
#Menin_inhibitors (revumenib, ziftomenib, enzomenib) are rapidly emerging as key agents in both frontline and R/R AML.
Triplet regimens (VEN/AZA + targeted therapy) show promise across AML subtypes.
Novel immunotherapies (bispecific FLT3×CD3) and CD123-directed therapy continue to expand the therapeutic landscape.
Real-world data in TP53-mutant AML remain critical for optimizing HMA selection.
Farooq A Wandroo retweeted
President @PEteiba has been visiting Members across the UK, this week in Birmingham.
He spoke at the Midland Metropolitan University Hospital about how the College speaks up for the profession and the importance of working together.
Thanks to our hosts and Members who attended.
Farooq A Wandroo retweeted
Venetoclax schedule in AML: 7 vs 14 vs 21 vs 28 days
nature.com/articles/s41408-0…
Farooq A Wandroo retweeted
The expansion of GLP-1 drug efficacy evidence in 2024, a concise review by @DanielJDrucker, a pioneer of the field nature.com/articles/s41574-0…
Farooq A Wandroo retweeted
‘We have been shocked at the awful racist and Islamophobic attacks that have taken place in UK cities over the past week.’
Dr @Mumtaz_Patel_1, acting RCP president, condemns the violent behaviour on the streets of UK cities: ow.ly/LfF950SRVNA
Farooq A Wandroo retweeted
Delighted that the @BritSocHaem @UKMyelomaSoc Good Practice Paper on the treatment of high risk transplant-eligible myeloma is now published. Many thanks to @MyMKaiser for his great input. #mmsm
British Journal of Haematology | Wiley Online Library onlinelibrary.wiley.com/doi/…
Farooq A Wandroo retweeted
Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management |American Journal of Hematology | Blood Research Journal | Wiley Online Library onlinelibrary.wiley.com/doi/… #mmsm
Farooq A Wandroo retweeted
Chemo-free regimens (TKIs-blinatumomab) highly effective in Ph+ALL; may replace intensive chemoRx and allo SCT in most such patients in the future.
Clinical Lymphoma, Myeloma and Leukemia
doi.org/10.1016/j.clml.2024.…
@NitinJainMD @NicholasShortMD @MDAndersonNews
#leusm
Farooq A Wandroo retweeted
Wishing good luck to all of the MRCP(UK) PACES candidates sitting their exams with our College this week! Our team is at Glasgow Royal Infirmary Tuesday to Friday and Sandwell General Hospital over the weekend. We'll be delivering exams across the UK this summer. #WeAreRCPSG
Farooq A Wandroo retweeted
Of 30 patients with severe #SickleCellDisease who were treated with gene-edited autologous hematopoietic stem and progenitor cells, 29 were free from vaso-occlusive crises for at least 12 consecutive months. Read the full CLIMB SCD-121 study results: nej.md/3UvzPDT
Farooq A Wandroo retweeted
A new study on the characterization of the B-cell receptor of monoclonal B lymphocytosis in siblings of patients with #chronicLymphocyticLeukemia ( #CLL ) provides insights into the early steps of the development of CLL. haematologica.org/article/vi…
Farooq A Wandroo retweeted
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers
|American Journal of Hematology | Wiley Online Library onlinelibrary.wiley.com/doi/…
Farooq A Wandroo retweeted
Ven Less is More: Ven 14 days non-inferior to 28 days in newly-diagnosed acute myeloid leukemia.
onlinelibrary.wiley.com/doi/…
Farooq A Wandroo retweeted
Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant haematologica.org/article/vi…
Farooq A Wandroo retweeted
People in England with sickle cell disorder and thalassaemia will have NHS access to the world’s first blood group genotyping test, it has been announced.
Read the latest #BSHNews story here: ow.ly/w2KU50QwcQu
Farooq A Wandroo retweeted
Aza + ven + gilteritinib highly effective in newly dx older FLT3-mut #AML: CR/CRi 96% and 18-month OS 72%. A new standard of care in this population.
@NicholasShortMD of @MDAndersonNews #Leukemia
ascopubs.org/doi/10.1200/JCO… @JCO_ASCO
#leusm



































